Ingersoll Rand Operating Cash Flow decreased by 60.0% to $199.70M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 22.1%, from $256.40M to $199.70M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 21.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $147.30M | $146.10M | $246.90M | $50.10M | $186.10M | $274.40M | $354.80M | $170.30M | $228.40M | $397.30M | $581.40M | $161.60M | $304.90M | $404.00M | $526.20M | $256.40M | $245.70M | $354.60M | $499.00M | $199.70M |
| QoQ Change | — | -0.8% | +69.0% | -79.7% | +271.5% | +47.4% | +29.3% | -52.0% | +34.1% | +73.9% | +46.3% | -72.2% | +88.7% | +32.5% | +30.2% | -51.3% | -4.2% | +44.3% | +40.7% | -60.0% |
| YoY Change | — | — | — | — | +26.3% | +87.8% | +43.7% | +239.9% | +22.7% | +44.8% | +63.9% | -5.1% | +33.5% | +1.7% | -9.5% | +58.7% | -19.4% | -12.2% | -5.2% | -22.1% |